UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 372

Sortiert nach

Myeloproliferative neoplasms (MPNs)

Blood reviews, 2020-07, Vol.42, p.100717-100717, Article 100717

Godfrey, Anna L.

2020

Volltextzugriff (PDF)

Life histories of myeloproliferative neoplasms inferred from phylogenies

Nature (London), 2022-02, Vol.602 (7895), p.162-168

2022

Volltextzugriff (PDF)

Essential thrombocythemia: challenges in clinical practice and future prospects

Blood, 2023-04, Vol.141 (16), p.1943-1953

2023

Volltextzugriff (PDF)

Effect of Mutation Order on Myeloproliferative Neoplasms

The New England journal of medicine, 2015-02, Vol.372 (7), p.601-612

2015

Volltextzugriff (PDF)

Clonal Architecture in Myeloproliferative Neoplasms: Old Dog, New Tricks?

HemaSphere, 2023-06, Vol.7 (6), p.e903-n/a

Godfrey, Anna L.

2023

Volltextzugriff (PDF)

Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice

Blood reviews, 2020-07, Vol.42, p.100708-100708, Article 100708

2020

Volltextzugriff (PDF)

DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype

Haematologica (Roma), 2015-11, Vol.100 (11), p.e438

2015

Volltextzugriff (PDF)

After 10 years of JAK2V617F: Disease biology and current management strategies in polycythaemia vera

Blood reviews, 2017-05, Vol.31 (3), p.101-118

2017

Volltextzugriff (PDF)

Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice

British journal of haematology, 2024-07

2024

Volltextzugriff (PDF)

Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features

Journal of clinical oncology, 2018-12, Vol.36 (34), p.3361-3369

2018

Volltextzugriff (PDF)

Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients

Leukemia, 2023-02, Vol.37 (2), p.348-358

2023

Volltextzugriff (PDF)

JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease

Blood, 2014-05, Vol.123 (20), p.3139-3151

2014

Volltextzugriff (PDF)

Inherited polygenic effects on common hematological traits influence clonal selection on JAK2V617F and the development of myeloproliferative neoplasms

Nature genetics, 2024-02, Vol.56 (2), p.273-280

2024

Volltextzugriff (PDF)

Driver Mutation Acquisition in Utero and Childhood Followed By Lifelong Clonal Evolution Underlie Myeloproliferative Neoplasms

Blood, 2020-11, Vol.136 (Supplement_2), p.LBA-1-LBA-1

2020

Volltextzugriff (PDF)

Changes in practice within a haematological malignancy diagnostic service: A 5‐year retrospective study

British journal of haematology, 2024-07, Vol.205 (1), p.378-381

2024

Volltextzugriff (PDF)

Low‐Risk Essential Thrombocythemia: A Comprehensive Review

HemaSphere, 2021-02, Vol.5 (2), p.e521-n/a

2021

Volltextzugriff (PDF)

Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline

British journal of haematology, 2024-01, Vol.204 (1), p.127-135

2024

Volltextzugriff (PDF)

Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment

Blood, 2021-05, Vol.137 (21), p.2992-2997

2021

Volltextzugriff (PDF)

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations

British journal of haematology, 2013-01, Vol.160 (1), p.25-34

2013

Volltextzugriff (PDF)

The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders

British journal of haematology, 2021-11, Vol.195 (3), p.338-351

2021

Volltextzugriff (PDF)

The management of myelofibrosis: A British Society for Haematology Guideline

British journal of haematology, 2024-01, Vol.204 (1), p.136-150

2024

Volltextzugriff (PDF)

Correction: Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients

Leukemia, 2023-02, Vol.37 (2), p.503-503

2023

Volltextzugriff (PDF)

RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability

Cell reports (Cambridge), 2015-12, Vol.13 (11), p.2345-2352

2015

Volltextzugriff (PDF)

JAK2V617F promotes replication fork stalling with disease-restricted impairment of the intra-S checkpoint response

Proceedings of the National Academy of Sciences - PNAS, 2014-10, Vol.111 (42), p.15190-15195

2014

Volltextzugriff (PDF)

1 – 25 von 372

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(318)
Mit Volltextzugriff
(339)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Myeloproliferative neoplasms (MPNs)

Life histories of myeloproliferative neoplasms inferred from phylogenies

Essential thrombocythemia: challenges in clinical practice and future prospects

Effect of Mutation Order on Myeloproliferative Neoplasms

Clonal Architecture in Myeloproliferative Neoplasms: Old Dog, New Tricks?

Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice

DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype

After 10 years of JAK2V617F: Disease biology and current management strategies in polycythaemia vera

Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice

Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features

Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients

JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease

Inherited polygenic effects on common hematological traits influence clonal selection on JAK2V617F and the development of myeloproliferative neoplasms

Driver Mutation Acquisition in Utero and Childhood Followed By Lifelong Clonal Evolution Underlie Myeloproliferative Neoplasms

Changes in practice within a haematological malignancy diagnostic service: A 5‐year retrospective study

Low‐Risk Essential Thrombocythemia: A Comprehensive Review

Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline

Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations

The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders

The management of myelofibrosis: A British Society for Haematology Guideline

Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib

Correction: Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients

RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability

JAK2V617F promotes replication fork stalling with disease-restricted impairment of the intra-S checkpoint response

Suchergebnisse filtern